| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |